Hinge Health Inc. $HNGE Stock Bought by Voya Investment Management LLC

Hinge Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Voya Investment Management LLC grew its stake in shares of Hinge Health Inc. (NYSE:HNGE - Free Report) by 53.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,196,896 shares of the company's stock after buying an additional 418,728 shares during the period. Voya Investment Management LLC owned 1.48% of Hinge Health worth $116,386,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. 11.2 Capital Management LLC acquired a new position in Hinge Health in the second quarter valued at $204,566,531. Assenagon Asset Management S.A. grew its position in Hinge Health by 2,141.9% during the third quarter. Assenagon Asset Management S.A. now owns 1,854,922 shares of the company's stock valued at $180,373,000 after acquiring an additional 1,772,182 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in Hinge Health by 225.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company's stock worth $44,852,000 after acquiring an additional 806,007 shares during the last quarter. Wellington Management Group LLP increased its stake in Hinge Health by 169.7% during the second quarter. Wellington Management Group LLP now owns 1,205,584 shares of the company's stock worth $100,063,000 after acquiring an additional 758,594 shares during the last quarter. Finally, Estuary Capital Management LP acquired a new stake in Hinge Health during the first quarter worth about $15,201,000.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. KeyCorp lifted their price objective on Hinge Health from $125.00 to $140.00 and gave the company an "overweight" rating in a research note on Friday, October 16th. Citizens Jmp increased their target price on shares of Hinge Health from $96.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 5th. Robert W. Baird increased their target price on shares of Hinge Health from $85.00 to $90.00 and gave the stock a "neutral" rating in a research report on Tuesday, September 22nd. Citigroup restated an "outperform" rating on shares of Hinge Health in a report on Monday, July 27th. Finally, Stifel Nicolaus lifted their price target on shares of Hinge Health from $130.00 to $135.00 and gave the company a "buy" rating in a research report on Tuesday, November 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, Hinge Health presently has a consensus rating of "Buy" and a consensus price target of $118.93.

Read Our Latest Analysis on Hinge Health

Insider Buying and Selling

In related news, CFO James Budge sold 35,907 shares of the firm's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $121.62, for a total transaction of $4,367,009.34. Following the sale, the chief financial officer directly owned 256,207 shares in the company, valued at approximately $31,159,895.34. This trade represents a 12.29% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Gabriel Mecklenburg sold 200,000 shares of the business's stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $122.41, for a total value of $24,482,000.00. Following the transaction, the chairman directly owned 200,000 shares in the company, valued at $24,482,000. This trade represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,259,288 shares of company stock worth $124,375,894 in the last ninety days. 18.92% of the stock is owned by corporate insiders.

Hinge Health Trading Up 0.1%

Shares of NYSE HNGE opened at $114.52 on Thursday. The stock has a fifty day moving average price of $105.29 and a 200 day moving average price of $72.02. Hinge Health Inc. has a 12-month low of $30.08 and a 12-month high of $126.40. The company has a market cap of $9.31 billion, a P/E ratio of 62.18, a P/E/G ratio of 1.61 and a beta of 1.19.

Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings data on Monday, November 2nd. The company reported $0.71 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.44. Hinge Health had a return on equity of 66.96% and a net margin of 21.02%. The company had revenue of $234.97 million for the quarter. During the same quarter in the prior year, the firm earned ($0.02) EPS. The company's revenue for the quarter was up 52.4% compared to the same quarter last year. On average, sell-side analysts forecast that Hinge Health Inc. will post 1.56 EPS for the current fiscal year.

About Hinge Health

(Free Report)

Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company's offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.

See Also

Want to see what other hedge funds are holding HNGE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hinge Health Inc. (NYSE:HNGE - Free Report).

Institutional Ownership by Quarter for Hinge Health (NYSE:HNGE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines